Skip to content

StellarexRecalls & reported problems across all models

Spectranetics Corporation · 8 models in the FDA device registry

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
27
Deaths reported
0
Injuries reported
2
Recalls
0

We found 8 models of Stellarex by Spectranetics Corporation in the FDA's device registry (GUDID). Together they are named in 27 adverse event reports in the FDA's MAUDE database, received between Apr 18, 2018 and Feb 21, 2023 — classified as 2 injuries, 25 malfunctions.

The most frequently reported specific device problem is “Material Rupture” (24 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works

Most reported Stellarex problems

Device problems

  • Material Rupture24
  • Deflation Problem1
  • Device Markings/Labelling Problem1
  • Difficult to Insert1

Patient problems

  • No Consequences Or Impact To Patient18
  • No Clinical Signs, Symptoms or Conditions8
  • Atherosclerosis1
  • Peripheral Vascular Disease1

Stellarex models

8 models, most reported first. Each model has its own page with its reports, recalls and device details.

Recent Stellarex adverse event reports

The 15 most recent reports across all models, in the reporter's own words as published by the FDA.

Other Spectranetics Corporation products

All Spectranetics Corporation devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page